These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 474641)

  • 1. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
    Burns B; Curry RH; Bell ME
    Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
    Shi YF; Xie X; Zhao CL
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
    Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
    Ip PP; Tse KY; Tam KF
    Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
    Bell SW; Kempson RL; Hendrickson MR
    Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle tumors of the vulva.
    Tavassoli FA; Norris HJ
    Obstet Gynecol; 1979 Feb; 53(2):213-7. PubMed ID: 418977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.
    Mayerhofer K; Obermair A; Windbichler G; Petru E; Kaider A; Hefler L; Czerwenka K; Leodolter S; Kainz C
    Gynecol Oncol; 1999 Aug; 74(2):196-201. PubMed ID: 10419731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas.
    Matoso A; Chen S; Plaza JA; Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2014 Oct; 38(10):1410-7. PubMed ID: 24832157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.
    Patil DT; Laskin WB; Fetsch JF; Miettinen M
    Am J Surg Pathol; 2011 Mar; 35(3):315-24. PubMed ID: 21297441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
    Fletcher JA; Morton CC; Pavelka K; Lage JM
    Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K; Demopoulos RI
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
    Clement PB; Young RH; Scully RE
    Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.
    Giuntoli RL; Gostout BS; DiMarco CS; Metzinger DS; Keeney GL
    J Reprod Med; 2007 Nov; 52(11):1001-10. PubMed ID: 18161397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bizarre leiomyoma of the uterus--a clinicopathological analysis of 21 cases].
    Zhao ZS
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):441-3. PubMed ID: 2076641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
    Zhu XQ; Lv JQ; Lin Y; Xiang M; Gao BH; Shi YF
    Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.
    Prayson RA; Goldblum JR; Hart WR
    Am J Surg Pathol; 1997 Apr; 21(4):383-91. PubMed ID: 9130984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S; Nakano H; Tsuneyoshi M
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.